News Martina Kovarova

(1 - 7 von 8
)

UNC to Create the Next Generation, Ultra-Long-Acting ...

news.unchealthcare.org
— L-R: Angela Wahl, PhD; Rahima Benhabbour, PhD; and Martina Kovarova, PhD. New project aims to provide long-lasting HIV treatment and/or ... › un...

New Anti-HIV Medication Provides Protection for Women and Infants |...

www.newswise.com
Each year, 1.5 million women living with HIV become pregnant. Without effective treatment, up to 45 percent of HIV-infected mothers will transmit the virus to...

Long-Acting Injectable Implant Shows Promise For HIV Treatment &...

www.mpo-mag.com
The solid implant dissolves slowly to release anti-HIV medication over time.

Long-acting injectable implant shows promise for HIV treatment and...

news.unchealthcare.org
... developed by UNC School of Medicine researchers Rahima Benhabbour, PhD and Martina Kovarova, PhD, is injected under the skin and ...

Long-acting Injectable implant shows promise for HIV treatment and...

www.newswise.com
Currently, a once-daily pill to prevent HIV infection is available. However, adherence to a once-daily regimen can be difficult for some people. Researchers fro

UNC to create and test injectable long-acting implant to prevent...

medicalxpress.com
... discontinuation of this form of PrEP," said Martina Kovarova, Ph.D., the study's co-principal investigator and an assistant professor in the UNC ...

UNC awarded $2.91 million to create new ultra-long-acting ...news.unchealthcare.org ›

news.unchealthcare.org
... higher than currently approved drugs,” said Martina Kovarova, PhD, associate professor of medicine at UNC and director of the project.
+1